BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yue W, Liu Y, Li X, Lv L, Huang J, Liu J. Curcumin ameliorates dextran sulfate sodium-induced colitis in mice via regulation of autophagy and intestinal immunity. Turk J Gastroenterol 2019;30:290-8. [PMID: 30923033 DOI: 10.5152/tjg.2019.18342] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Caban M, Lewandowska U. Polyphenols and the potential mechanisms of their therapeutic benefits against inflammatory bowel diseases. Journal of Functional Foods 2022;95:105181. [DOI: 10.1016/j.jff.2022.105181] [Reference Citation Analysis]
2 Lin Y, Liu H, Bu L, Chen C, Ye X. Review of the Effects and Mechanism of Curcumin in the Treatment of Inflammatory Bowel Disease. Front Pharmacol 2022;13:908077. [DOI: 10.3389/fphar.2022.908077] [Reference Citation Analysis]
3 Rahiman N, Markina YV, Kesharwani P, Johnston TP, Sahebkar A. Curcumin-based nanotechnology approaches and therapeutics in restoration of autoimmune diseases. J Control Release 2022;348:264-86. [PMID: 35649486 DOI: 10.1016/j.jconrel.2022.05.046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Hong J, Pandurangan A. Protective Effects of Curcumin-Regulated Intestinal Epithelial Autophagy on Inflammatory Bowel Disease in Mice. Gastroenterology Research and Practice 2022;2022:1-7. [DOI: 10.1155/2022/2163931] [Reference Citation Analysis]
5 Shi H, Wang D, Chen W, Li Y, Si G, Yang T, Alhumaydhi FA. Quality of Evidence Supporting the Role of Supplement Curcumin for the Treatment of Ulcerative Colitis: An Overview of Systematic Reviews. Gastroenterology Research and Practice 2022;2022:1-13. [DOI: 10.1155/2022/3967935] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
6 Lai J, Tang Y, Yang F, Chen J, Huang FH, Yang J, Wang L, Qin D, Law BY, Wu AG, Wu JM. Targeting autophagy in ethnomedicine against human diseases. J Ethnopharmacol 2022;282:114516. [PMID: 34487846 DOI: 10.1016/j.jep.2021.114516] [Reference Citation Analysis]
7 Shi B, Liu S, Huang A, Zhou M, Sun B, Cao H, Shan J, Sun B, Lin J. Revealing the Mechanism of Friedelin in the Treatment of Ulcerative Colitis Based on Network Pharmacology and Experimental Verification. Evid Based Complement Alternat Med 2021;2021:4451779. [PMID: 34765000 DOI: 10.1155/2021/4451779] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
8 Peng Y, Ao M, Dong B, Jiang Y, Yu L, Chen Z, Hu C, Xu R. Anti-Inflammatory Effects of Curcumin in the Inflammatory Diseases: Status, Limitations and Countermeasures. Drug Des Devel Ther 2021;15:4503-25. [PMID: 34754179 DOI: 10.2147/DDDT.S327378] [Cited by in Crossref: 21] [Cited by in F6Publishing: 32] [Article Influence: 21.0] [Reference Citation Analysis]
9 Amalraj A, Varma K, Jacob J, Kuttappan S. Efficacy and safety of a gut health product (Actbiome) prepared by incorporation of asafoetida-curcumin complex onto the turmeric dietary fiber in the management of gut health and intestinal microflora in healthy subjects: A randomized, double-blind, placebo controlled study. Bioactive Carbohydrates and Dietary Fibre 2021;26:100280. [DOI: 10.1016/j.bcdf.2021.100280] [Reference Citation Analysis]
10 Qiao D, Zhang Z, Zhang Y, Chen Q, Chen Y, Tang Y, Sun X, Tang Z, Dai Y. Regulation of Endoplasmic Reticulum Stress-Autophagy: A Potential Therapeutic Target for Ulcerative Colitis. Front Pharmacol 2021;12:697360. [PMID: 34588980 DOI: 10.3389/fphar.2021.697360] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
11 Kang ZP, Wang MX, Wu TT, Liu DY, Wang HY, Long J, Zhao HM, Zhong YB. Curcumin Alleviated Dextran Sulfate Sodium-Induced Colitis by Regulating M1/M2 Macrophage Polarization and TLRs Signaling Pathway. Evid Based Complement Alternat Med 2021;2021:3334994. [PMID: 34567209 DOI: 10.1155/2021/3334994] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
12 Zhang Y, Yamamoto T, Hayashi S, Kadowaki M. Suppression of plasmacytoid dendritic cell migration to colonic isolated lymphoid follicles abrogates the development of colitis. Biomed Pharmacother 2021;141:111881. [PMID: 34246191 DOI: 10.1016/j.biopha.2021.111881] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Thein W, Po WW, Choi WS, Sohn UD. Autophagy and Digestive Disorders: Advances in Understanding and Therapeutic Approaches. Biomol Ther (Seoul) 2021;29:353-64. [PMID: 34127572 DOI: 10.4062/biomolther.2021.086] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
14 Liu G, Feng S, Sun Y, Wang D, Shao P, Sun P. Colonic macrophage-targeted curcumin nanoparticles alleviate DSS-induced colitis in mice through the NF-kappa B pathway. Food Bioscience 2021;41:101089. [DOI: 10.1016/j.fbio.2021.101089] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Karthikeyan A, Young KN, Moniruzzaman M, Beyene AM, Do K, Kalaiselvi S, Min T. Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook. Pharmaceutics 2021;13:484. [PMID: 33918207 DOI: 10.3390/pharmaceutics13040484] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
16 Machado APDF, Geraldi MV, do Nascimento RP, Moya AMTM, Vezza T, Diez-Echave P, Gálvez JJ, Cazarin CBB, Maróstica Júnior MR. Polyphenols from food by-products: An alternative or complementary therapy to IBD conventional treatments. Food Res Int 2021;140:110018. [PMID: 33648249 DOI: 10.1016/j.foodres.2020.110018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
17 Fallahi F, Borran S, Ashrafizadeh M, Zarrabi A, Pourhanifeh MH, Khaksary Mahabady M, Sahebkar A, Mirzaei H. Curcumin and inflammatory bowel diseases: From in vitro studies to clinical trials. Mol Immunol 2021;130:20-30. [PMID: 33348246 DOI: 10.1016/j.molimm.2020.11.016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
18 Ashrafizadeh M, Najafi M, Mohammadinejad R, Farkhondeh T, Samarghandian S. Berberine Administration in Treatment of Colitis: A Review. Curr Drug Targets 2020;21:1385-93. [PMID: 32564751 DOI: 10.2174/1389450121666200621193758] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Rotrekl D, Šalamúnová P, Paráková L, Baďo O, Saloň I, Štěpánek F, Hanuš J, Hošek J. Composites of yeast glucan particles and curcumin lead to improvement of dextran sulfate sodium-induced acute bowel inflammation in rats. Carbohydr Polym 2021;252:117142. [PMID: 33183601 DOI: 10.1016/j.carbpol.2020.117142] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
20 Bilski J, Wojcik D, Danielak A, Mazur-bialy A, Magierowski M, Tønnesen K, Brzozowski B, Surmiak M, Magierowska K, Pajdo R, Ptak-belowska A, Brzozowski T. Alternative Therapy in the Prevention of Experimental and Clinical Inflammatory Bowel Disease. Impact of Regular Physical Activity, Intestinal Alkaline Phosphatase and Herbal Products. CPD 2020;26:2936-50. [DOI: 10.2174/1381612826666200427090127] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Cao F, Liu J, Sha B, Pan H. Natural Products: Experimental Efficient Agents for Inflammatory Bowel Disease Therapy. CPD 2020;25:4893-913. [DOI: 10.2174/1381612825666191216154224] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]